Latest Regulatory Approval News

Midas Minerals has identified multiple drill-ready gold targets at its Newington Project in Western Australia, with drilling planned for the September quarter pending approvals. Meanwhile, exploration continues at the Challa Project as assay results are awaited.

Bounty Oil and Gas NL reported steady progress in Queensland oil production and development, increasing reserves to 313,000 barrels, while pursuing a Federal Court review of the PEP 11 offshore permit refusal. The company also completed a modest $231,000 entitlement offer to support ongoing exploration and development.

Equity Story Group Ltd reported a robust 56% revenue increase in the March 2025 quarter, driven by strong fund performance and membership growth, alongside a strategic investment and plans to acquire Baker Young Limited.

Reef Casino Trust’s responsible entity confirms ongoing confidential negotiations with two parties over potential acquisition proposals exceeding A$200 million, though no deal is assured.

Arizona Lithium advances its Prairie Project with a pioneering commercial development plan for lithium brine extraction, regulatory approvals, and a $1.3 million capital raise to fund initial production.

Alligator Energy Limited has made significant strides in its uranium exploration and development projects, securing critical regulatory approvals and advancing field operations while maintaining a robust cash position. The company’s strategic investments and ongoing drilling programs position it well amid a strengthening uranium market.

Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

EV Resources Limited advances its position in the critical antimony market with a 70% stake acquisition in Mexico’s Los Lirios project and full ownership of Utah’s historic Coyote Creek claims, setting the stage for exploration and development.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

CZR Resources has terminated its prior deal with Miracle Iron and endorsed a superior A$75 million cash offer from the Rio Tinto-led Robe River Iron Associates JV for its Robe Mesa Project. The company retains promising gold and titanium-vanadium assets while preparing for shareholder approval.

Global Lithium Resources has resumed its Definitive Feasibility Study at the Manna Lithium Project, focusing on cost optimization and project economics, while advancing heritage and native title agreements. The company also reported significant board changes and a robust cash position heading into 2025.